HOBOKEN, N.J.–(BUSINESS WIRE)–Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley’s trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wil
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care
